You’ve done your research on BPC-157. You’ve read about the gut healing, the tendon repair, the impressive recovery stories. Now you’re staring at a tiny vial wondering: how much of this stuff am I actually supposed to take?
You’re not alone. Dosing is the single most confusing part of using this peptide, and for good reason. The research uses one approach, the online forums suggest another, and somehow you’re supposed to figure out what makes sense for your body.
Let’s untangle this together.
Why BPC-157 dosing feels like guesswork
Here’s the uncomfortable truth that most peptide websites won’t tell you: we don’t have large-scale human clinical trials establishing an “official” dose for BPC-157. Most of what we know comes from animal studies, small human trials, and a whole lot of anecdotal experience from people experimenting on themselves.
That doesn’t mean we’re flying completely blind. It means you need to understand where the numbers come from so you can make informed decisions about your own body.
The research that exists is genuinely promising. But translating rat doses to human doses involves some educated math, not certainty.
What the animal research actually tells us
Most BPC-157 studies use rats, and the doses typically fall in a specific range: 10 micrograms per kilogram of body weight up to about 50 mcg/kg. Some studies push higher, but that’s the sweet spot where researchers consistently see results.
So what does that mean for a human?
If you weigh around 80 kg (about 176 pounds), a direct translation of the lower research dose would put you at 800 mcg per day. The higher end would be 4,000 mcg daily.
But here’s where it gets interesting. When scientists convert animal doses to human equivalent doses, they don’t just multiply by body weight. They use something called allometric scaling, which accounts for differences in metabolism between species. Rats burn through compounds faster than we do.
When you apply that conversion, the human equivalent dose actually comes out lower than a straight weight-based calculation. Somewhere in the range of 1.6 mcg/kg to 8 mcg/kg for humans.
For that same 80 kg person, that’s roughly 128 mcg to 640 mcg per day.
The practical takeaway: Research math suggests humans might need less than people typically use, not more.
What people are actually taking in the real world
Scroll through any peptide forum and you’ll see doses ranging from 250 mcg once daily all the way up to 500 mcg twice daily. Some people go even higher.
The most common protocols I see people discussing fall into a few camps:
The conservative approach involves 250 mcg once or twice daily. People using this dose often report slower but steady results, particularly for chronic issues or general gut health support.
The moderate approach sits at 500 mcg once or twice daily. This is probably the most popular range for injury recovery and more acute concerns.
The aggressive approach pushes 750 mcg to 1,000 mcg or more daily, sometimes split into multiple injections. Usually reserved for serious injuries or people who haven’t responded to lower doses.
What’s notable is that many experienced users report diminishing returns above certain thresholds. Doubling your dose doesn’t seem to double your results. Some people find their sweet spot at 250 mcg while others need 500 mcg to notice anything.
The practical takeaway: More isn’t automatically better. Starting lower gives you room to adjust upward if needed.
Injection vs. oral dosing: does it change the math?
This is where things get genuinely complicated.
BPC-157 is one of the few peptides that shows activity when taken orally. It’s remarkably stable in stomach acid, which is unusual for a peptide. Most get destroyed before they can do anything.
However, oral bioavailability is still lower than injection. How much lower? We don’t have precise human data, but estimates suggest you might need 2 to 10 times the injectable dose to achieve similar systemic effects.
That means if someone responds well to 250 mcg injected, they might need 500 mcg to 2,500 mcg orally for comparable results.
Some people specifically want BPC-157 for gut issues and prefer oral dosing because it delivers the peptide directly to the digestive tract. For gut-specific applications, this local delivery might actually be more efficient than injection.
For systemic effects like tendon healing or reducing inflammation throughout the body, subcutaneous injection remains the more predictable option.
The practical takeaway: Match your delivery method to your goal. Gut healing might favor oral. Injury recovery might favor injection.
The timing question: once daily or split doses?
BPC-157 has a relatively short half-life in the body, somewhere around 4 to 6 hours based on the limited pharmacokinetic data we have. This has led many people to split their daily dose into two injections, usually morning and evening.
The theory makes sense. More frequent dosing maintains more stable blood levels throughout the day.
But here’s the counterargument: we don’t actually know if stable blood levels matter more than peak concentration for BPC-157’s effects. Some healing mechanisms might respond better to higher peaks even if they don’t last as long.
Plenty of people report excellent results with once-daily dosing. Others swear by splitting it up.
The practical takeaway: If once daily works for you, there’s no proven reason to complicate your protocol. If results plateau, splitting the dose is a reasonable experiment.
How long do people typically run BPC-157?
Most protocols run between 4 and 12 weeks, depending on what someone is trying to address.
For acute injuries, many people use BPC-157 for 4 to 6 weeks and then reassess. Chronic issues or slower-healing injuries often warrant longer runs, sometimes 8 to 12 weeks.
Some people cycle it, taking breaks of several weeks between runs. Others use it continuously for extended periods. We don’t have safety data on very long-term use, which is worth keeping in mind.
The anecdotal consensus suggests that most people see the majority of their benefits within the first 4 to 6 weeks. If nothing is happening by week 4, the dose or approach might need adjusting.
The practical takeaway: Set a timeline before you start. Reassess at 4 weeks. Don’t run indefinitely without a clear reason.
Local injection vs. subcutaneous: where you inject might matter
For injury-specific use, some people inject BPC-157 as close to the affected area as possible. The idea is to deliver higher local concentrations directly where healing needs to happen.
Others inject subcutaneously into belly fat regardless of where their injury is, relying on systemic distribution.
Both approaches have their advocates. The research doesn’t clearly favor one method, though some animal studies did use local injection near the injury site.
If you’re dealing with a specific tendon or joint issue, local injection is a reasonable approach. For general gut healing or systemic inflammation, subcutaneous injection anywhere convenient makes sense.
The practical takeaway: Location probably matters less than consistency. Pick an approach and stick with it long enough to evaluate results.
Building your own starting point
Given everything we’ve covered, here’s a reasonable framework for thinking about your own protocol:
Start at the lower end of common dosing, around 250 mcg daily. This aligns reasonably well with the research-derived human equivalent calculations and gives you room to adjust.
Run this for at least 2 weeks before deciding it isn’t working. Peptide effects often build gradually.
If you’re not seeing any response by week 3 or 4, consider increasing to 500 mcg daily, either as a single dose or split.
Track something measurable. Pain levels, range of motion, how your gut feels after meals. Subjective impressions fade, but notes don’t.
And if you’re dealing with a complex injury or have underlying health conditions, this is genuinely a conversation worth having with a doctor who understands peptides. Not because the internet told you to consult a professional, but because they can help you interpret what’s actually happening in your body and adjust accordingly.
The honest bottom line
BPC-157 dosing involves educated guessing, not precision. The research gives us a reasonable starting range. Community experience helps refine it. But your optimal dose is something you discover through careful self-experimentation.
Start conservative. Pay attention. Adjust thoughtfully. That’s the most reliable protocol anyone can offer you right now.